Literature DB >> 17828292

Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate.

K Rea1, M Roche, D P Finn.   

Abstract

Recent physiological, pharmacological and anatomical studies provide evidence that one of the main roles of the endocannabinoid system in the brain is the regulation of gamma-aminobutyric acid (GABA) and glutamate release. This article aims to review this evidence in the context of its implications for pain. We first provide a brief overview of supraspinal regulation of nociception, followed by a review of the evidence that the brain's endocannabinoid system modulates nociception. We look in detail at regulation of supraspinal GABAergic and glutamatergic neurons by the endocannabinoid system and by exogenously administered cannabinoids. Finally, we review the evidence that cannabinoid-mediated modulation of pain involves modulation of GABAergic and glutamatergic neurotransmission in key brain regions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828292      PMCID: PMC2190023          DOI: 10.1038/sj.bjp.0707440

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  185 in total

1.  Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations.

Authors:  N Hájos; I Katona; S S Naiem; K MacKie; C Ledent; I Mody; T F Freund
Journal:  Eur J Neurosci       Date:  2000-09       Impact factor: 3.386

2.  Molecular composition of the endocannabinoid system at glutamatergic synapses.

Authors:  István Katona; Gabriella M Urbán; Matthew Wallace; Catherine Ledent; Kwang-Mook Jung; Daniele Piomelli; Ken Mackie; Tamás F Freund
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

Review 3.  PPAR-gamma: a nuclear receptor with affinity for cannabinoids.

Authors:  Sumner Burstein
Journal:  Life Sci       Date:  2005-08-19       Impact factor: 5.037

4.  Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice.

Authors:  M Kathmann; B Weber; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-01       Impact factor: 3.000

5.  Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment.

Authors:  X Wu; E D French
Journal:  Neuropharmacology       Date:  2000-01-28       Impact factor: 5.250

Review 6.  The induction of pain: an integrative review.

Authors:  M J Millan
Journal:  Prog Neurobiol       Date:  1999-01       Impact factor: 11.685

7.  Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat.

Authors:  J D Jentsch; C D Verrico; D Le; R H Roth
Journal:  Neurosci Lett       Date:  1998-05-01       Impact factor: 3.046

8.  CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.

Authors:  Astrid Cannich; Carsten T Wotjak; Kornelia Kamprath; Heike Hermann; Beat Lutz; Giovanni Marsicano
Journal:  Learn Mem       Date:  2004 Sep-Oct       Impact factor: 2.460

9.  Antihyperalgesic effect of the cannabinoid agonist WIN55,212-2 is mediated through an interaction with spinal metabotropic glutamate-5 receptors in rats.

Authors:  Aldric T Hama; Mark O Urban
Journal:  Neurosci Lett       Date:  2004-03-18       Impact factor: 3.046

10.  The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study.

Authors:  J M Ng Cheong Ton; G A Gerhardt; M Friedemann; A M Etgen; G M Rose; N S Sharpless; E L Gardner
Journal:  Brain Res       Date:  1988-06-07       Impact factor: 3.252

View more
  21 in total

1.  Cannabinoids and their actions.

Authors:  S P H Alexander; M Randall
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

2.  Effects of GABAA receptors in nucleus cuneiformis on the cannabinoid antinociception using the formalin test.

Authors:  Junjie Chen; Parisa Hasanein; Alireza Komaki; Siamak Yari
Journal:  Psychopharmacology (Berl)       Date:  2021-03-13       Impact factor: 4.530

Review 3.  Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics.

Authors:  Michael Remesic; Victor J Hruby; Frank Porreca; Yeon Sun Lee
Journal:  ACS Chem Neurosci       Date:  2017-04-07       Impact factor: 4.418

4.  TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception.

Authors:  Catia Giordano; Luigia Cristino; Livio Luongo; Dario Siniscalco; Stefania Petrosino; Fabiana Piscitelli; Ida Marabese; Luisa Gatta; Francesca Rossi; Roberta Imperatore; Enza Palazzo; Vito de Novellis; Vincenzo Di Marzo; Sabatino Maione
Journal:  Cereb Cortex       Date:  2011-12-01       Impact factor: 5.357

Review 5.  Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative?

Authors:  Amber L Milligan; Thomas A Szabo-Pardi; Michael D Burton
Journal:  J Dual Diagn       Date:  2019-10-09

6.  Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action.

Authors:  Sabatino Maione; Fabiana Piscitelli; Luisa Gatta; Daniela Vita; Luciano De Petrocellis; Enza Palazzo; Vito de Novellis; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

7.  Selection for stress-induced analgesia affects the mouse hippocampal transcriptome.

Authors:  Pawel Lisowski; Adrian M Stankiewicz; Joanna Goscik; Marek Wieczorek; Lech Zwierzchowski; Artur H Swiergiel
Journal:  J Mol Neurosci       Date:  2011-12-16       Impact factor: 3.444

Review 8.  β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia.

Authors:  Kirsten M Raehal; Laura M Bohn
Journal:  Handb Exp Pharmacol       Date:  2014

9.  Brain 2-Arachidonoylglycerol Levels Are Dramatically and Rapidly Increased Under Acute Ischemia-Injury Which Is Prevented by Microwave Irradiation.

Authors:  Stephen A Brose; Svetlana A Golovko; Mikhail Y Golovko
Journal:  Lipids       Date:  2016-03-28       Impact factor: 1.880

10.  Potentiation by WIN 55,212-2 of GABA-activated currents in rat trigeminal ganglion neurones.

Authors:  Zhi-Wang Li; Jian Zhang; Chang-han Ouyang; Chao-Ying Li; Feng-Bo Zhao; Yu-Wei Liu; Yong-Xun Ai; Wang-Ping Hu
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.